Recurrence in Nonseminomatous Germ Cell Testis Tumor Patients with No Viable Tumor at Postchemotherapy Retroperitoneal Lymph Node Dissection

Urology

Volumn 70, Issue 6, 2007, Pages 1173-1178

  Spiess, Philippe E ^a   Tannir, Nizar M ^a   Brown, Gordon A ^a   Liu, Ping ^a   Tu, Shi Ming ^a   Evans, James G ^a   Pisters, Louis L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADOLESCENT; ADULT; ARTICLE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; TESTIS TUMOR; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; RETROPERITONEAL SPACE; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 37349042506     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.07.021     Document Type: Article

References (9)

1. Stephenson A.J., Bosl G.J., Motzer R.J., et al. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol 23 (2005) 2781-2782
2. Donohue J.P., Thornhill J.A., Foster R.S., et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 149 (1993) 237-243
3. Donohue J.P., Thornhill J.A., Foster R.S., et al. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). J Urol 153 (1995) 85-89
4. Logothetis C.J., Swanson D.A., Dexeus F., et al. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients. J Clin Oncol 5 (1987) 906-911
5. Horwich A., Norman A., Fisher C., et al. Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis. J Urol 151 (1994) 72-77
6. Spiess P.E., Brown G.A., Liu P., et al. Recurrence pattern and proposed surveillance protocol following post-chemotherapy RPLND. J Urol 177 (2007) 131-138
7. Kaplan E.L., and Meier E.P. Nonparametric estimation from incomplete observations. J Am Statist 53 (1958) 457-481
8. Toner G.C., Panicek D.M., Heelan R.T., et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8 (1990) 1683-1694
9. Debono D.J., Heilman D.K., Einhorn L.H., et al. Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 15 (1997) 1455-1464